Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Enterprise Value: 537.68M for Feb. 29, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| February 29, 2024 | 537.68M |
| February 28, 2024 | 537.68M |
| February 27, 2024 | 537.68M |
| February 26, 2024 | 537.68M |
| February 23, 2024 | 537.68M |
| February 22, 2024 | 537.68M |
| February 21, 2024 | 537.68M |
| February 20, 2024 | 537.68M |
| February 16, 2024 | 539.68M |
| February 15, 2024 | 544.69M |
| February 14, 2024 | 539.68M |
| February 13, 2024 | 543.69M |
| February 12, 2024 | 542.69M |
| February 09, 2024 | 540.18M |
| February 08, 2024 | 537.68M |
| February 07, 2024 | 534.67M |
| February 06, 2024 | 534.17M |
| February 05, 2024 | 534.67M |
| February 02, 2024 | 534.17M |
| February 01, 2024 | 532.67M |
| January 31, 2024 | 537.68M |
| January 30, 2024 | 537.18M |
| January 29, 2024 | 538.68M |
| January 26, 2024 | 536.67M |
| January 25, 2024 | 537.18M |
| Date | Value |
|---|---|
| January 24, 2024 | 538.18M |
| January 23, 2024 | 532.17M |
| January 22, 2024 | 536.67M |
| January 19, 2024 | 543.69M |
| January 18, 2024 | 551.20M |
| January 17, 2024 | 554.71M |
| January 16, 2024 | 552.70M |
| January 12, 2024 | 552.70M |
| January 11, 2024 | 554.21M |
| January 10, 2024 | 554.71M |
| January 09, 2024 | 553.20M |
| January 08, 2024 | 557.21M |
| January 05, 2024 | 552.70M |
| January 04, 2024 | 559.22M |
| January 03, 2024 | 560.22M |
| January 02, 2024 | 566.23M |
| December 29, 2023 | 560.22M |
| December 28, 2023 | 556.21M |
| December 27, 2023 | 561.72M |
| December 26, 2023 | 555.21M |
| December 22, 2023 | 552.20M |
| December 21, 2023 | 549.20M |
| December 20, 2023 | 542.69M |
| December 19, 2023 | 545.69M |
| December 18, 2023 | 545.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-128.83M
Minimum
Nov 14 2022
1.472B
Maximum
Aug 23 2021
291.06M
Average
163.45M
Median
Sep 26 2023
Enterprise Value Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 11.34B |
| Immunogen Inc (DELISTED) | -- |
| AbbVie Inc | 349.85B |
| Assure Holdings Corp | 17.40M |
| Harpoon Therapeutics Inc (DELISTED) | 460.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -22.04M |
| Total Expenses (Quarterly) | 25.28M |
| EPS Diluted (Quarterly) | -0.44 |
| Earnings Yield | -14.50% |